Quince Therapeutics (QNCX) Intangibles (2022 - 2025)

Quince Therapeutics has reported Intangibles for 4 years, with the latest figure at $67.8 million in Q4 2025.

• On a quarterly basis, Intangibles rose 12.95% year-over-year to $67.8 million in Q4 2025; TTM through Dec 2025 was $67.8 million, a 12.95% increase from a year earlier, with the FY2025 full-year figure at $67.8 million, up 12.95% from the prior year.
• Intangibles was $67.8 million for Q4 2025 at Quince Therapeutics, roughly flat from $67.7 million in the prior quarter.
• The five-year high for Intangibles was $67.8 million in Q4 2025, with the low at $5.9 million in Q2 2022.
• Average Intangibles over 4 years is $49.6 million, with a median of $62.3 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Intangibles jumped 979.19% in 2023, then decreased 5.7% in 2024.
• Over 4 years, Intangibles stood at $5.9 million in 2022, then surged by 979.19% to $63.7 million in 2023, then fell by 5.7% to $60.0 million in 2024, then increased by 12.95% to $67.8 million in 2025.
• The last three Intangibles figures came in at $67.8 million (Q4 2025), $67.7 million (Q3 2025), and $67.6 million (Q2 2025), per Business Quant data.